Máximo Bernabeu-Wittel

Dr. Máximo Bernabeu-Wittel

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2003 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JMJOSE GARNACHO MONTERO
JOSE GARNACHO MONTERO
COC. Ortiz‐Leyba
C. Ortiz‐Leyba
FJF. J. Jimenez‐Jimenez
F. J. Jimenez‐Jimenez
ABA. E. Barrero‐Almodovar
A. E. Barrero‐Almodovar
JGJosé Luis García Garmendia
José Luis García Garmendia
JMJ. Madrazo‐Osuna
J. Madrazo‐Osuna
We prospectively evaluated the efficacy and toxicity of intravenously administered colistin in 35 episodes of ventilator-associated pneumonia (VAP) du

1 June 2011 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
MBMáximo Bernabeu-Wittel
Máximo Bernabeu-Wittel
MOM. Ollero-Baturone
M. Ollero-Baturone
LML. Moreno-Gaviño
L. Moreno-Gaviño
BBBosco Baron-Franco
Bosco Baron-Franco
AFA. Fuertes
A. Fuertes
AFA. Fernández-Moyano
A. Fernández-Moyano

12 June 2014 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
JBJ. Bousquet
J. Bousquet
AAAntonio Addis
Antonio Addis
IAIan Adcock
Ian Adcock
IAI. Agache
I. Agache
AAAlvar Agustí
Alvar Agustí
Torsten ZuberbierTorsten Zuberbier
Torsten Zuberbier
The objective of Integrated Care Pathways for Airway Diseases (AIRWAYS-ICPs) is to launch a collaboration to develop multi-sectoral care pathways for chronic respiratory diseases in European countries and regions. AIRWAYS-ICPs has strategic relevance to the European Union Health Strategy and will add value to existing public health knowledge by: 1) proposing a common framework of care pathways for chronic respiratory diseases, which will facilitate comparability and trans-national initiatives; 2) informing cost-effective policy development, strengthening in particular those on smoking and environmental exposure; 3) aiding risk stratification in chronic disease patients, using a common strategy; 4) having a significant impact on the health of citizens in the short term (reduction of morbidity, improvement of education in children and of work in adults) and in the long-term (healthy ageing); 5) proposing a common simulation tool to assist physicians; and 6) ultimately reducing the healthcare burden (emergency visits, avoidable hospitalisations, disability and costs) while improving quality of life. In the longer term, the incidence of disease may be reduced by innovative prevention strategies. AIRWAYSICPs was initiated by Area 5 of the Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing. All stakeholders are involved (health and social care, patients, and policy makers).

1 March 2009 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
YFY. Fernández
Y. Fernández
MBMáximo Bernabeu-Wittel
Máximo Bernabeu-Wittel
JGJ.S. García-Morillo
J.S. García-Morillo

15 February 2001 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
FCF. J. Caballero-Granado
F. J. Caballero-Granado
BBB. Becerril
B. Becerril
LCL. Cuberos
L. Cuberos
MBMáximo Bernabeu-Wittel
Máximo Bernabeu-Wittel
JCJosé M. Cisneros
José M. Cisneros
JPJerónimo Pachón
Jerónimo Pachón
The mortality rate of patients with cases of enterococcal bacteremia is high, although it has often been related to the patients' underlying conditio

26 April 1999 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
MBMáximo Bernabeu-Wittel
Máximo Bernabeu-Wittel
JPJerónimo Pachón
Jerónimo Pachón
AAA. Alarcón
A. Alarcón
LCLuis Fernando Lopez Cortes
Luis Fernando Lopez Cortes
PVP. Viciana
P. Viciana
FCF. J. Caballero-Granado
F. J. Caballero-Granado
MURINE TYPHUS (MT), a zoonosis that is caused by Rickettsia typhi, occurs all over the world, with endemic areas in North and South America, Southeast Asia, Africa, Australia, and some southern European countries.1-10 The importance of this illness has been underestimated. It is more frequent than is commonly believed and represents a worldwide health problem.11 Studies on its prevalence have shown that it also occurs in Spain.12,13 Sporadic cases have been reported in Seville, Huelva, and Murcia,7-9 but, to our knowledge, no extensive studies have been performed to investigate its clinical and epidemiological characteristics. Therefore, its real incidence is not known.